Vimarsana
Biggest News Aggregation in the World

Exone Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exone Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exone Biologic Today - Breaking & Trending Today

NurExone Announces Voting Results from 2024 Annual Meeting - Vimarsana News

NurExone Announces Voting Results from 2024 Annual Meeting

NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders...

NurExone Shareholders Back Key Resolutions - Vimarsana News

NurExone Shareholders Back Key Resolutions

EnerSpar Corp. (TSE:NRX) has released an update. NurExone Biologic Inc. shareholders showed strong support for company proposals during the 2024 An...

Source: biztoc.com
NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine - Vimarsana News

NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine

19.04.2024 - TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) - NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Lior Shaltiel, CEO and Director ... Seite 1

Baystreet.ca - Aurora, Blockchaink2, Loblaw at 52-Week Highs on News - Vimarsana News

Baystreet.ca - Aurora, Blockchaink2, Loblaw at 52-Week Highs on News

Aurora Cannabis Inc. (T.ACB) hit a new 52-week high of $4.69 Tuesday. Aurora announced today that Simona King , a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer ...

Baystreet.ca - Aurora, Blockchaink2, Loblaw at 52-Week Highs on News - Vimarsana News

Baystreet.ca - Aurora, Blockchaink2, Loblaw at 52-Week Highs on News

Aurora Cannabis Inc. (T.ACB) hit a new 52-week high of $4.69 Tuesday. Aurora announced today that Simona King , a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer ...